Research Article
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study
Table 2
Reasons given for discontinuation of teriparatide therapy for those patients who reported early or late discontinuation.
| | Time of discontinuation | early | late | | N (%) | n (%) |
| | Concerns about treatment outweighed the benefits | 27 (42.2) | 26 (38.2) | | Cost issues—difficulty paying for it | 19 (29.7) | 28 (41.2) | | Taken as long as physician prescribed | 11 (17.2) | 10 (14.7) | | Problems with injecting | 8 (12.5) | 3 (4.4) | | Did not believe it was beneficial | 4 (6.3) | 7 (10.3) | | Too hard to follow all the steps necessary to use Forteo | 3 (4.7) | 0 (0.0) | | Reason unspecified | 2 (3.1) | 2 (2.9) |
|
|
aNote that some patients reported more than one reason. A total of 64 patients discontinued early and 68 discontinued late.
|
